Home
>
National Drug Code (NDC)
>
modafinil
modafinil - 55253-801-30 - (modafinil)
Drug Information of modafinil
| Product NDC: | 55253-801 |
| Proprietary Name: | modafinil |
| Non Proprietary Name: | modafinil |
| Active Ingredient(s): | 100 mg/1 & nbsp; modafinil |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of modafinil
| Product NDC: | 55253-801 |
| Labeler Name: | CIMA Labs Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020717 |
| Marketing Category: | NDA AUTHORIZED GENERIC |
| Start Marketing Date: | 20120329 |
Package Information of modafinil
| Package NDC: | 55253-801-30 |
| Package Description: | 30 TABLET in 1 BOTTLE (55253-801-30) |
NDC Information of modafinil
| NDC Code | 55253-801-30 |
| Proprietary Name | modafinil |
| Package Description | 30 TABLET in 1 BOTTLE (55253-801-30) |
| Product NDC | 55253-801 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | modafinil |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20120329 |
| Marketing Category Name | NDA AUTHORIZED GENERIC |
| Labeler Name | CIMA Labs Inc |
| Substance Name | MODAFINIL |
| Strength Number | 100 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Central Nervous System Stimulation [PE],Increased Sympathetic Activity [PE],Sympathomimetic-like Agent [EPC] |
